Walmart, Kroger Raise Prices of Rapid COVID-19 Tests After Agreement with Biden Admin Expires

Covid19 Antigen Rapid Test Diagnostic
by Sebastian Hughes


Retail giants Walmart and Kroger have each raised the price of BinaxNOW rapid COVID-19 tests after a deal made with President Joe Biden expired in mid-December, FOX Business reported.

The September deal had the companies sell the antigen self-test kits made by Abbott Laboratories for $14 for 100 days, FOX Business reported. The cost of the tests will now be $19.98.

“The program ended in mid-December, and while other retailers increased prices in mid-December, Walmart held the $14.00 through the holidays before increasing the price,” a Walmart spokesperson told FOX Business in a statement. There are also purchase limits in place due to the high demand for tests.

A Kroger spokesperson confirmed “that pricing program has now phased out and retail pricing has been reinstated” and will be selling the two-test kits for $23.99, FOX Business reported. It is unknown if Amazon, who was also a part of the deal, is raising its prices, but the company does not currently have the BinaxNOW tests available for sale.

Test shortages complicated the holidays as the highly contagious Omicron variant spread throughout the U.S. The Biden administration said the shortage was not anticipated because no one expected a variant like Omicron to spread so rapidly.

“We should have had more tests available, but hopefully now as we get into the first couple weeks in January, that’ll get much better,” President Joe Biden’s chief medical adviser, Dr. Anthony Fauci, said in late December.

The surge has led to an all-time high in recorded cases in the U.S., though data from South Africa showed the Omicron variant was milder than others and does not increase deaths at the same rate as cases.

– – –

Sebastian Hughes is a reporter at Daily Caller News Foundation.
Photo “Rapid COVID test” by dronepicr CC BY 2.0.




Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected].

Related posts